Clear Street Group Inc. Buys 22,294 Shares of Aimei Health Technology Co., Ltd. $AFJK

Posted by Brenda Bartman on Jun 14th, 2026

Clear Street Group Inc. boosted its stake in shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Free Report) by 36.5% in the fourth quarter, Holdings Channel reports. The firm owned 83,337 shares of the company’s stock after acquiring an additional 22,294 shares during the period. Clear Street Group Inc.’s holdings in Aimei Health Technology were worth $5,334,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in AFJK. Berkley W R Corp boosted its position in Aimei Health Technology by 5.9% during the third quarter. Berkley W R Corp now owns 450,655 shares of the company’s stock worth $5,101,000 after purchasing an additional 25,294 shares during the period. Quarry LP boosted its position in Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after purchasing an additional 10,000 shares during the period. Geode Capital Management LLC bought a new stake in Aimei Health Technology during the fourth quarter worth approximately $413,000. Dakota Wealth Management bought a new stake in Aimei Health Technology during the fourth quarter worth approximately $406,000. Finally, Jane Street Group LLC bought a new stake in Aimei Health Technology during the fourth quarter worth approximately $302,000. Institutional investors own 45.58% of the company’s stock.

Aimei Health Technology Trading Down 4.1%

AFJK opened at $33.01 on Friday. Aimei Health Technology Co., Ltd. has a 1-year low of $6.75 and a 1-year high of $130.37. The stock has a market capitalization of $104.64 million, a price-to-earnings ratio of 183.39 and a beta of 0.22. The business has a 50 day moving average of $41.26 and a 200-day moving average of $40.33.

Aimei Health Technology (NASDAQ:AFJK – Get Free Report) last posted its quarterly earnings data on Monday, May 4th. The company reported $0.02 earnings per share for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

View Our Latest Stock Analysis on AFJK

Aimei Health Technology Company Profile

(Free Report)

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.